Ibrahim NK - Search Results

1

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Buzdar AU, Singletary SE, Valero V, Booser DJ, Ibrahim NK, Rahman Z, Theriault RL, Walters R, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD, Strom E, Thomas E, Hunt K, Ames F, Berry D, Hortobagyi GN. Buzdar AU, et al. Among authors: ibrahim nk. Clin Cancer Res. 2002 May;8(5):1073-9. Clin Cancer Res. 2002. PMID: 12006521 Clinical Trial.

2

Aromatase inhibitors: current status.

Ibrahim NK, Buzdar AU. Ibrahim NK, et al. Am J Clin Oncol. 1995 Oct;18(5):407-17. doi: 10.1097/00000421-199510000-00010. Am J Clin Oncol. 1995. PMID: 7572758 Review.

3

Paclitaxel-containing combination chemotherapy for metastatic breast cancer.

Hortobagyi GN, Ibrahim N. Hortobagyi GN, et al. Semin Oncol. 1996 Feb;23(1 Suppl 1):53-7. Semin Oncol. 1996. PMID: 8629039

4

Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome.

Ibrahim NK, Frye DK, Buzdar AU, Walters RS, Hortobagyi GN. Ibrahim NK, et al. Arch Intern Med. 1996 Apr 22;156(8):882-8. Arch Intern Med. 1996. PMID: 8774207

5

The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.

Hortobagyi GN, Holmes FA, Ibrahim N, Champlin R, Buzdar AU. Hortobagyi GN, et al. Semin Oncol. 1997 Feb;24(1 Suppl 3):S30-3. Semin Oncol. 1997. PMID: 9071338 Review.

6

Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.

Hoff PM, Valero V, Ibrahim N, Willey J, Hortobagyi GN. Hoff PM, et al. Cancer. 1998 Mar 1;82(5):965-9. doi: 10.1002/(sici)1097-0142(19980301)82:5<965::aid-cncr23>3.0.co;2-y. Cancer. 1998. PMID: 9486588 Clinical Trial.

7

Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol.

Yu D, Liu B, Jing T, Sun D, Price JE, Singletary SE, Ibrahim N, Hortobagyi GN, Hung MC. Yu D, et al. Oncogene. 1998 Apr 23;16(16):2087-94. doi: 10.1038/sj.onc.1201729. Oncogene. 1998. PMID: 9572489

8

Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience.

Ibrahim NK, Hortobagyi GN, Ewer M, Ali MK, Asmar L, Theriault RL, Fraschini G, Frye DK, Buzdar AU. Ibrahim NK, et al. Cancer Chemother Pharmacol. 1999;43(6):471-8. doi: 10.1007/s002800050926. Cancer Chemother Pharmacol. 1999. PMID: 10321507

9

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

Ibrahim NK, Rahman Z, Valero V, Willey J, Theriault RL, Buzdar AU, Murray JL 3rd, Bast R, Hortobagyi GN. Ibrahim NK, et al. Cancer. 1999 Oct 1;86(7):1251-7. doi: 10.1002/(sici)1097-0142(19991001)86:7<1251::aid-cncr21>3.0.co;2-f. Cancer. 1999. PMID: 10506711 Clinical Trial.

10

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M, Strom E, Hunt K, Ames F, Hortobagyi GN. Buzdar AU, et al. J Clin Oncol. 1999 Nov;17(11):3412-7. doi: 10.1200/JCO.1999.17.11.3412. J Clin Oncol. 1999. PMID: 10550135 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters